QuantRx Granted 510(k) Clearance for RapidSense Methamphetamine Test
QuantRx Biomedical Corporation has announced that the FDA has granted the Company 510(k) clearance on its RapidSense drugs-of-abuse (DOA) Methamphetamine test.
Read MorePosted by Clinical Lab Products | Jan 7, 2009 | Miscellaneous |
QuantRx Biomedical Corporation has announced that the FDA has granted the Company 510(k) clearance on its RapidSense drugs-of-abuse (DOA) Methamphetamine test.
Read MorePosted by Clinical Lab Products | Jan 3, 2009 | Miscellaneous |
Rapid tests are changing the face of cardiac diagnostics for both acute and chronic situations.
Read MorePosted by Clinical Lab Products | Dec 10, 2008 | Cancer, Miscellaneous |
Quidel Corp recently presented data from a correlation study for its QuickVue iFOB (immunochemical Fecal Occult Blood) test for colorectal cancer (CRC) screening.
Read MorePosted by Clinical Lab Products | Sep 17, 2008 | Miscellaneous |
A look at today’s respiratory viral diagnostics
Read MorePosted by Clinical Lab Products | Sep 16, 2008 | Miscellaneous |
Complex viral genetics and overlapping disease symptoms pose challenges
Read More